Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9602 USD | -1.31% | -0.92% | +11.01% |
May. 08 | Earnings Flash (KPTI) KARYOPHARM THERAPEUTICS Reports Q1 Revenue $33.1M, vs. Street Est of $34.5M | MT |
May. 08 | Transcript : Karyopharm Therapeutics Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 145M | Sales 2025 * | 165M | Capitalization | 120M |
---|---|---|---|---|---|
Net income 2024 * | -149M | Net income 2025 * | -146M | EV / Sales 2024 * | 1.75 x |
Net Debt 2024 * | 134M | Net cash position 2025 * | - | EV / Sales 2025 * | 0.73 x |
P/E ratio 2024 * |
-0.78
x | P/E ratio 2025 * |
-1.13
x | Employees | 325 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.8% |
Latest transcript on Karyopharm Therapeutics Inc.
1 day | -1.31% | ||
1 week | -0.92% | ||
Current month | -0.92% | ||
1 month | -12.71% | ||
3 months | -37.24% | ||
6 months | +14.51% | ||
Current year | +11.01% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 20-02-25 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 19-02-24 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 13-10-02 |
Barry Greene
BRD | Director/Board Member | 60 | 12-12-31 |
Director/Board Member | 59 | 13-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.9602 | -1.31% | 1,750,556 |
24-06-06 | 0.9729 | -2.16% | 1,429,751 |
24-06-05 | 0.9944 | +7.27% | 1,932,931 |
24-06-04 | 0.927 | -6.14% | 1,078,902 |
24-06-03 | 0.9876 | +1.91% | 1,894,544 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.01% | 120M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- KPTI Stock